- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Newcastle Disease Vaccine will have significant change from previous year. By the most conservative estimates of global Newcastle Disease Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 301.2 million in 2020. Over the next five years the Newcastle Disease Vaccine market will register a 3.6% CAGR in terms of revenue, the global market size will reach US$ 347.4 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Newcastle Disease Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Live Vaccines
Killed Vaccines
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Chicken
Duck & Goose
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Newcastle Disease Vaccine Consumption 2016-2026
2.1.2 Newcastle Disease Vaccine Consumption CAGR by Region
2.2 Newcastle Disease Vaccine Segment by Type
2.2.1 Live Vaccines
2.2.2 Killed Vaccines
2.3 Newcastle Disease Vaccine Sales by Type
2.3.1 Global Newcastle Disease Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Newcastle Disease Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Newcastle Disease Vaccine Sale Price by Type (2016-2021)
2.4 Newcastle Disease Vaccine Segment by Application
2.4.1 Chicken
2.4.2 Duck & Goose
2.4.3 Other
2.5 Newcastle Disease Vaccine Sales by Application
2.5.1 Global Newcastle Disease Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Newcastle Disease Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Newcastle Disease Vaccine Sale Price by Application (2016-2021)
3 Global Newcastle Disease Vaccine by Company
3.1 Global Newcastle Disease Vaccine Sales Market Share by Company
3.1.1 Global Newcastle Disease Vaccine Sales by Company (2019-2021)
3.1.2 Global Newcastle Disease Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Newcastle Disease Vaccine Revenue Market Share by Company
3.2.1 Global Newcastle Disease Vaccine Revenue by Company (2019-2021)
3.2.2 Global Newcastle Disease Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Newcastle Disease Vaccine Sale Price by Company
3.4 Global Manufacturers Newcastle Disease Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Newcastle Disease Vaccine Product Location Distribution
3.4.2 Players Newcastle Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Newcastle Disease Vaccine by Region
4.1 Global Newcastle Disease Vaccine by Region
4.1.1 Global Newcastle Disease Vaccine Sales by Region
4.1.2 Global Newcastle Disease Vaccine Revenue by Region
4.2 Americas Newcastle Disease Vaccine Sales Growth
4.3 APAC Newcastle Disease Vaccine Sales Growth
4.4 Europe Newcastle Disease Vaccine Sales Growth
4.5 Middle East & Africa Newcastle Disease Vaccine Sales Growth
5 Americas
5.1 Americas Newcastle Disease Vaccine Sales by Country
5.1.1 Americas Newcastle Disease Vaccine Sales by Country (2016-2021)
5.1.2 Americas Newcastle Disease Vaccine Revenue by Country (2016-2021)
5.2 Americas Newcastle Disease Vaccine Sales by Type
5.3 Americas Newcastle Disease Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Newcastle Disease Vaccine Sales by Region
6.1.1 APAC Newcastle Disease Vaccine Sales by Region (2016-2021)
6.1.2 APAC Newcastle Disease Vaccine Revenue by Region (2016-2021)
6.2 APAC Newcastle Disease Vaccine Sales by Type
6.3 APAC Newcastle Disease Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Newcastle Disease Vaccine by Country
7.1.1 Europe Newcastle Disease Vaccine Sales by Country (2016-2021)
7.1.2 Europe Newcastle Disease Vaccine Revenue by Country (2016-2021)
7.2 Europe Newcastle Disease Vaccine Sales by Type
7.3 Europe Newcastle Disease Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Newcastle Disease Vaccine by Country
8.1.1 Middle East & Africa Newcastle Disease Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Newcastle Disease Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Newcastle Disease Vaccine Sales by Type
8.3 Middle East & Africa Newcastle Disease Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Newcastle Disease Vaccine Distributors
10.3 Newcastle Disease Vaccine Customer
11 Global Newcastle Disease Vaccine Market Forecast
11.1 Global Newcastle Disease Vaccine Forecast by Region
11.1.1 Global Newcastle Disease Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Newcastle Disease Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Newcastle Disease Vaccine Forecast by Type
11.7 Global Newcastle Disease Vaccine Forecast by Application
12 Key Players Analysis
12.1 Merial
12.1.1 Merial Company Information
12.1.2 Merial Newcastle Disease Vaccine Product Offered
12.1.3 Merial Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Merial Main Business Overview
12.1.5 Merial Latest Developments
12.2 CEVA
12.2.1 CEVA Company Information
12.2.2 CEVA Newcastle Disease Vaccine Product Offered
12.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 CEVA Main Business Overview
12.2.5 CEVA Latest Developments
12.3 QYH Biotech
12.3.1 QYH Biotech Company Information
12.3.2 QYH Biotech Newcastle Disease Vaccine Product Offered
12.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 QYH Biotech Main Business Overview
12.3.5 QYH Biotech Latest Developments
12.4 Ringpu Biology
12.4.1 Ringpu Biology Company Information
12.4.2 Ringpu Biology Newcastle Disease Vaccine Product Offered
12.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Ringpu Biology Main Business Overview
12.4.5 Ringpu Biology Latest Developments
12.5 Yebio
12.5.1 Yebio Company Information
12.5.2 Yebio Newcastle Disease Vaccine Product Offered
12.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Yebio Main Business Overview
12.5.5 Yebio Latest Developments
12.6 Harbin Veterinary Research Institute
12.6.1 Harbin Veterinary Research Institute Company Information
12.6.2 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Offered
12.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Harbin Veterinary Research Institute Main Business Overview
12.6.5 Harbin Veterinary Research Institute Latest Developments
12.7 Merck Animal Health
12.7.1 Merck Animal Health Company Information
12.7.2 Merck Animal Health Newcastle Disease Vaccine Product Offered
12.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Merck Animal Health Main Business Overview
12.7.5 Merck Animal Health Latest Developments
12.8 DHN
12.8.1 DHN Company Information
12.8.2 DHN Newcastle Disease Vaccine Product Offered
12.8.3 DHN Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 DHN Main Business Overview
12.8.5 DHN Latest Developments
12.9 Zoetis
12.9.1 Zoetis Company Information
12.9.2 Zoetis Newcastle Disease Vaccine Product Offered
12.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Zoetis Main Business Overview
12.9.5 Zoetis Latest Developments
12.10 ChengDu Tecbond
12.10.1 ChengDu Tecbond Company Information
12.10.2 ChengDu Tecbond Newcastle Disease Vaccine Product Offered
12.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 ChengDu Tecbond Main Business Overview
12.10.5 ChengDu Tecbond Latest Developments
12.11 Elanco (Lohmann)
12.11.1 Elanco (Lohmann) Company Information
12.11.2 Elanco (Lohmann) Newcastle Disease Vaccine Product Offered
12.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Elanco (Lohmann) Main Business Overview
12.11.5 Elanco (Lohmann) Latest Developments
12.12 FATRO
12.12.1 FATRO Company Information
12.12.2 FATRO Newcastle Disease Vaccine Product Offered
12.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 FATRO Main Business Overview
12.12.5 FATRO Latest Developments
12.13 CAVAC
12.13.1 CAVAC Company Information
12.13.2 CAVAC Newcastle Disease Vaccine Product Offered
12.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 CAVAC Main Business Overview
12.13.5 CAVAC Latest Developments
12.14 Vaksindo
12.14.1 Vaksindo Company Information
12.14.2 Vaksindo Newcastle Disease Vaccine Product Offered
12.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Vaksindo Main Business Overview
12.14.5 Vaksindo Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Newcastle Disease Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Live Vaccines
Table 3. Major Players of Killed Vaccines
Table 4. Global Newcastle Disease Vaccine Sales by Type (2016-2021) & (M Doses)
Table 5. Global Newcastle Disease Vaccine Sales Market Share by Type (2016-2021)
Table 6. Global Newcastle Disease Vaccine Revenue by Type (2016-2021) & ($ million)
Table 7. Global Newcastle Disease Vaccine Revenue Market Share by Type (2016-2021)
Table 8. Global Newcastle Disease Vaccine Sale Price by Type (2016-2021)
Table 9. Global Newcastle Disease Vaccine Sales by Application (2016-2021) & (M Doses)
Table 10. Global Newcastle Disease Vaccine Sales Market Share by Application (2016-2021)
Table 11. Global Newcastle Disease Vaccine Value by Application (2016-2021)
Table 12. Global Newcastle Disease Vaccine Revenue Market Share by Application (2016-2021)
Table 13. Global Newcastle Disease Vaccine Sale Price by Application (2016-2021)
Table 14. Global Newcastle Disease Vaccine Sales by Company (2019-2021) & (M Doses)
Table 15. Global Newcastle Disease Vaccine Sales Market Share by Company (2019-2021)
Table 16. Global Newcastle Disease Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Newcastle Disease Vaccine Revenue Market Share by Company (2019-2021)
Table 18. Global Newcastle Disease Vaccine Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Newcastle Disease Vaccine Producing Area Distribution and Sales Area
Table 20. Players Newcastle Disease Vaccine Products Offered
Table 21. Newcastle Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Newcastle Disease Vaccine Sales by Region (2016-2021) (M Doses)
Table 25. Global Newcastle Disease Vaccine Sales Market Share by Region (2016-2021)
Table 26. Global Newcastle Disease Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Newcastle Disease Vaccine Revenue Market Share by Region (2016-2021)
Table 28. Americas Newcastle Disease Vaccine Sales by Country (2016-2021) & (M Doses)
Table 29. Americas Newcastle Disease Vaccine Sales Market Share by Country (2016-2021)
Table 30. Americas Newcastle Disease Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Newcastle Disease Vaccine Revenue Market Share by Country (2016-2021)
Table 32. Americas Newcastle Disease Vaccine Sales by Type (2016-2021) & (M Doses)
Table 33. Americas Newcastle Disease Vaccine Sales Market Share by Type (2016-2021)
Table 34. Americas Newcastle Disease Vaccine Sales by Application (2016-2021) & (M Doses)
Table 35. Americas Newcastle Disease Vaccine Sales Market Share by Application (2016-2021)
Table 36. APAC Newcastle Disease Vaccine Sales by Region (2016-2021) & (M Doses)
Table 37. APAC Newcastle Disease Vaccine Sales Market Share by Region (2016-2021)
Table 38. APAC Newcastle Disease Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Newcastle Disease Vaccine Revenue Market Share by Region (2016-2021)
Table 40. APAC Newcastle Disease Vaccine Sales by Type (2016-2021) & (M Doses)
Table 41. APAC Newcastle Disease Vaccine Sales Market Share by Type (2016-2021)
Table 42. APAC Newcastle Disease Vaccine Sales by Application (2016-2021) & (M Doses)
Table 43. APAC Newcastle Disease Vaccine Sales Market Share by Application (2016-2021)
Table 44. Europe Newcastle Disease Vaccine Sales by Country (2016-2021) & (M Doses)
Table 45. Europe Newcastle Disease Vaccine Sales Market Share by Country (2016-2021)
Table 46. Europe Newcastle Disease Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Newcastle Disease Vaccine Revenue Market Share by Country (2016-2021)
Table 48. Europe Newcastle Disease Vaccine Sales by Type (2016-2021) & (M Doses)
Table 49. Europe Newcastle Disease Vaccine Sales Market Share by Type (2016-2021)
Table 50. Europe Newcastle Disease Vaccine Sales by Application (2016-2021) & (M Doses)
Table 51. Europe Newcastle Disease Vaccine Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Newcastle Disease Vaccine Sales by Country (2016-2021) & (M Doses)
Table 53. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Newcastle Disease Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Newcastle Disease Vaccine Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Newcastle Disease Vaccine Sales by Type (2016-2021) & (M Doses)
Table 57. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Newcastle Disease Vaccine Sales by Application (2016-2021) & (M Doses)
Table 59. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Newcastle Disease Vaccine
Table 61. Key Application and Potential Industries of Newcastle Disease Vaccine
Table 62. Key Challenges of Newcastle Disease Vaccine
Table 63. Key Trends of Newcastle Disease Vaccine
Table 64. Newcastle Disease Vaccine Distributors List
Table 65. Newcastle Disease Vaccine Customer List
Table 66. Global Newcastle Disease Vaccine Sales Forecast by Region (2021-2026) & (M Doses)
Table 67. Global Newcastle Disease Vaccine Consumption Market Forecast by Region
Table 68. Global Newcastle Disease Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Newcastle Disease Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Newcastle Disease Vaccine Sales Forecast by Country (2021-2026) & (M Doses)
Table 71. Americas Newcastle Disease Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Newcastle Disease Vaccine Sales Forecast by Region (2021-2026) & (M Doses)
Table 73. APAC Newcastle Disease Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Newcastle Disease Vaccine Sales Forecast by Country (2021-2026) & (M Doses)
Table 75. Europe Newcastle Disease Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Newcastle Disease Vaccine Sales Forecast by Country (2021-2026) & (M Doses)
Table 77. Middle East & Africa Newcastle Disease Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Newcastle Disease Vaccine Sales Forecast by Type (2021-2026) & (M Doses)
Table 79. Global Newcastle Disease Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Newcastle Disease Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Newcastle Disease Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Newcastle Disease Vaccine Sales Forecast by Application (2021-2026) & (M Doses)
Table 83. Global Newcastle Disease Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Newcastle Disease Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Newcastle Disease Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 86. Merial Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. Merial Newcastle Disease Vaccine Product Offered
Table 88. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 89. Merial Main Business
Table 90. Merial Latest Developments
Table 91. CEVA Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. CEVA Newcastle Disease Vaccine Product Offered
Table 93. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 94. CEVA Main Business
Table 95. CEVA Latest Developments
Table 96. QYH Biotech Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. QYH Biotech Newcastle Disease Vaccine Product Offered
Table 98. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 99. QYH Biotech Main Business
Table 100. QYH Biotech Latest Developments
Table 101. Ringpu Biology Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 102. Ringpu Biology Newcastle Disease Vaccine Product Offered
Table 103. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 104. Ringpu Biology Main Business
Table 105. Ringpu Biology Latest Developments
Table 106. Yebio Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 107. Yebio Newcastle Disease Vaccine Product Offered
Table 108. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 109. Yebio Main Business
Table 110. Yebio Latest Developments
Table 111. Harbin Veterinary Research Institute Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 112. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Offered
Table 113. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 114. Harbin Veterinary Research Institute Main Business
Table 115. Harbin Veterinary Research Institute Latest Developments
Table 116. Merck Animal Health Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 117. Merck Animal Health Newcastle Disease Vaccine Product Offered
Table 118. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 119. Merck Animal Health Main Business
Table 120. Merck Animal Health Latest Developments
Table 121. DHN Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 122. DHN Newcastle Disease Vaccine Product Offered
Table 123. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 124. DHN Main Business
Table 125. DHN Latest Developments
Table 126. Zoetis Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 127. Zoetis Newcastle Disease Vaccine Product Offered
Table 128. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 129. Zoetis Main Business
Table 130. Zoetis Latest Developments
Table 131. ChengDu Tecbond Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 132. ChengDu Tecbond Newcastle Disease Vaccine Product Offered
Table 133. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 134. ChengDu Tecbond Main Business
Table 135. ChengDu Tecbond Latest Developments
Table 136. Elanco (Lohmann) Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 137. Elanco (Lohmann) Newcastle Disease Vaccine Product Offered
Table 138. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 139. Elanco (Lohmann) Main Business
Table 140. Elanco (Lohmann) Latest Developments
Table 141. FATRO Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 142. FATRO Newcastle Disease Vaccine Product Offered
Table 143. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 144. FATRO Main Business
Table 145. FATRO Latest Developments
Table 146. CAVAC Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 147. CAVAC Newcastle Disease Vaccine Product Offered
Table 148. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 149. CAVAC Main Business
Table 150. CAVAC Latest Developments
Table 151. Vaksindo Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 152. Vaksindo Newcastle Disease Vaccine Product Offered
Table 153. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 154. Vaksindo Main Business
Table 155. Vaksindo Latest Developments
List of Figures
Figure 1. Picture of Newcastle Disease Vaccine
Figure 2. Newcastle Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Newcastle Disease Vaccine Sales Growth Rate 2016-2026 (M Doses)
Figure 7. Global Newcastle Disease Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Newcastle Disease Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Live Vaccines
Figure 10. Product Picture of Killed Vaccines
Figure 11. Global Newcastle Disease Vaccine Sales Market Share by Type in 2020
Figure 12. Global Newcastle Disease Vaccine Revenue Market Share by Type (2016-2021)
Figure 13. Newcastle Disease Vaccine Consumed in Chicken
Figure 14. Global Newcastle Disease Vaccine Market: Chicken (2016-2021) & (M Doses)
Figure 15. Newcastle Disease Vaccine Consumed in Duck & Goose
Figure 16. Global Newcastle Disease Vaccine Market: Duck & Goose (2016-2021) & (M Doses)
Figure 17. Newcastle Disease Vaccine Consumed in Other
Figure 18. Global Newcastle Disease Vaccine Market: Other (2016-2021) & (M Doses)
Figure 19. Global Newcastle Disease Vaccine Sales Market Share by Application (2016-2021)
Figure 20. Global Newcastle Disease Vaccine Revenue Market Share by Application in 2020
Figure 21. Newcastle Disease Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Newcastle Disease Vaccine Revenue Market Share by Company in 2020
Figure 23. Global Newcastle Disease Vaccine Sales Market Share by Regions (2016-2021)
Figure 24. Global Newcastle Disease Vaccine Revenue Market Share by Region in 2020
Figure 25. Americas Newcastle Disease Vaccine Sales 2016-2021 (M Doses)
Figure 26. Americas Newcastle Disease Vaccine Revenue 2016-2021 ($ Millions)
Figure 27. APAC Newcastle Disease Vaccine Sales 2016-2021 (M Doses)
Figure 28. APAC Newcastle Disease Vaccine Revenue 2016-2021 ($ Millions)
Figure 29. Europe Newcastle Disease Vaccine Sales 2016-2021 (M Doses)
Figure 30. Europe Newcastle Disease Vaccine Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Newcastle Disease Vaccine Sales 2016-2021 (M Doses)
Figure 32. Middle East & Africa Newcastle Disease Vaccine Revenue 2016-2021 ($ Millions)
Figure 33. Americas Newcastle Disease Vaccine Sales Market Share by Country in 2020
Figure 34. Americas Newcastle Disease Vaccine Revenue Market Share by Country in 2020
Figure 35. Americas Newcastle Disease Vaccine Sales Market Share by Type in 2020
Figure 36. Americas Newcastle Disease Vaccine Sales Market Share by Application in 2020
Figure 37. United States Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Newcastle Disease Vaccine Sales Market Share by Region in 2020
Figure 42. APAC Newcastle Disease Vaccine Revenue Market Share by Regions in 2020
Figure 43. APAC Newcastle Disease Vaccine Sales Market Share by Type in 2020
Figure 44. APAC Newcastle Disease Vaccine Sales Market Share by Application in 2020
Figure 45. China Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Newcastle Disease Vaccine Sales Market Share by Country in 2020
Figure 52. Europe Newcastle Disease Vaccine Revenue Market Share by Country in 2020
Figure 53. Europe Newcastle Disease Vaccine Sales Market Share by Type in 2020
Figure 54. Europe Newcastle Disease Vaccine Sales Market Share by Application in 2020
Figure 55. Germany Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Newcastle Disease Vaccine Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Application in 2020
Figure 64. Egypt Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Newcastle Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
